Cargando…
The role of necroptosis in cancer biology and therapy
Apoptosis resistance is to a large extent a major obstacle leading to chemotherapy failure during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is considered to be a promising approach to overcoming this problem. Necroptosis is a regulated necrotic cell death modality...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532150/ https://www.ncbi.nlm.nih.gov/pubmed/31122251 http://dx.doi.org/10.1186/s12943-019-1029-8 |
_version_ | 1783420953592594432 |
---|---|
author | Gong, Yitao Fan, Zhiyao Luo, Guopei Yang, Chao Huang, Qiuyi Fan, Kun Cheng, He Jin, Kaizhou Ni, Quanxing Yu, Xianjun Liu, Chen |
author_facet | Gong, Yitao Fan, Zhiyao Luo, Guopei Yang, Chao Huang, Qiuyi Fan, Kun Cheng, He Jin, Kaizhou Ni, Quanxing Yu, Xianjun Liu, Chen |
author_sort | Gong, Yitao |
collection | PubMed |
description | Apoptosis resistance is to a large extent a major obstacle leading to chemotherapy failure during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is considered to be a promising approach to overcoming this problem. Necroptosis is a regulated necrotic cell death modality in a caspase-independent fashion and is mainly mediated by Receptor-Interacting Protein 1 (RIP1), RIP3, and Mixed Lineage Kinase Domain-Like (MLKL). Necroptosis serves as an alternative mode of programmed cell death overcoming apoptosis resistance and may trigger and amplify antitumor immunity in cancer therapy. The role of necroptosis in cancer is complicated. The expression of key regulators of the necroptotic pathway is generally downregulated in cancer cells, suggesting that cancer cells may also evade necroptosis to survive; however, in certain types of cancer, the expression level of key mediators is elevated. Necroptosis can elicit strong adaptive immune responses that may defend against tumor progression; however, the recruited inflammatory response may also promote tumorigenesis and cancer metastasis, and necroptosis may generate an immunosuppressive tumor microenvironment. Necroptosis also reportedly promotes oncogenesis and cancer metastasis despite evidence demonstrating its antimetastatic role in cancer. In addition, necroptotic microenvironments can direct lineage commitment to determine cancer subtype development in liver cancer. A plethora of compounds and drugs targeting necroptosis exhibit potential antitumor efficacy, but their clinical feasibility must be validated. Better knowledge of the necroptotic pathway mechanism and its physiological and pathological functions is urgently required to solve the remaining mysteries surrounding the role of necroptosis in cancer. In this review, we briefly introduce the molecular mechanism and characteristics of necroptosis, the interplay between necroptosis and other cell death mechanisms, crosstalk of necroptosis and metabolic signaling and detection methods. We also summarize the intricate role of necroptosis in tumor progression, cancer metastasis, prognosis of cancer patients, cancer immunity regulation, cancer subtype determination and cancer therapeutics. |
format | Online Article Text |
id | pubmed-6532150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65321502019-05-28 The role of necroptosis in cancer biology and therapy Gong, Yitao Fan, Zhiyao Luo, Guopei Yang, Chao Huang, Qiuyi Fan, Kun Cheng, He Jin, Kaizhou Ni, Quanxing Yu, Xianjun Liu, Chen Mol Cancer Review Apoptosis resistance is to a large extent a major obstacle leading to chemotherapy failure during cancer treatment. Bypassing the apoptotic pathway to induce cancer cell death is considered to be a promising approach to overcoming this problem. Necroptosis is a regulated necrotic cell death modality in a caspase-independent fashion and is mainly mediated by Receptor-Interacting Protein 1 (RIP1), RIP3, and Mixed Lineage Kinase Domain-Like (MLKL). Necroptosis serves as an alternative mode of programmed cell death overcoming apoptosis resistance and may trigger and amplify antitumor immunity in cancer therapy. The role of necroptosis in cancer is complicated. The expression of key regulators of the necroptotic pathway is generally downregulated in cancer cells, suggesting that cancer cells may also evade necroptosis to survive; however, in certain types of cancer, the expression level of key mediators is elevated. Necroptosis can elicit strong adaptive immune responses that may defend against tumor progression; however, the recruited inflammatory response may also promote tumorigenesis and cancer metastasis, and necroptosis may generate an immunosuppressive tumor microenvironment. Necroptosis also reportedly promotes oncogenesis and cancer metastasis despite evidence demonstrating its antimetastatic role in cancer. In addition, necroptotic microenvironments can direct lineage commitment to determine cancer subtype development in liver cancer. A plethora of compounds and drugs targeting necroptosis exhibit potential antitumor efficacy, but their clinical feasibility must be validated. Better knowledge of the necroptotic pathway mechanism and its physiological and pathological functions is urgently required to solve the remaining mysteries surrounding the role of necroptosis in cancer. In this review, we briefly introduce the molecular mechanism and characteristics of necroptosis, the interplay between necroptosis and other cell death mechanisms, crosstalk of necroptosis and metabolic signaling and detection methods. We also summarize the intricate role of necroptosis in tumor progression, cancer metastasis, prognosis of cancer patients, cancer immunity regulation, cancer subtype determination and cancer therapeutics. BioMed Central 2019-05-23 /pmc/articles/PMC6532150/ /pubmed/31122251 http://dx.doi.org/10.1186/s12943-019-1029-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Gong, Yitao Fan, Zhiyao Luo, Guopei Yang, Chao Huang, Qiuyi Fan, Kun Cheng, He Jin, Kaizhou Ni, Quanxing Yu, Xianjun Liu, Chen The role of necroptosis in cancer biology and therapy |
title | The role of necroptosis in cancer biology and therapy |
title_full | The role of necroptosis in cancer biology and therapy |
title_fullStr | The role of necroptosis in cancer biology and therapy |
title_full_unstemmed | The role of necroptosis in cancer biology and therapy |
title_short | The role of necroptosis in cancer biology and therapy |
title_sort | role of necroptosis in cancer biology and therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532150/ https://www.ncbi.nlm.nih.gov/pubmed/31122251 http://dx.doi.org/10.1186/s12943-019-1029-8 |
work_keys_str_mv | AT gongyitao theroleofnecroptosisincancerbiologyandtherapy AT fanzhiyao theroleofnecroptosisincancerbiologyandtherapy AT luoguopei theroleofnecroptosisincancerbiologyandtherapy AT yangchao theroleofnecroptosisincancerbiologyandtherapy AT huangqiuyi theroleofnecroptosisincancerbiologyandtherapy AT fankun theroleofnecroptosisincancerbiologyandtherapy AT chenghe theroleofnecroptosisincancerbiologyandtherapy AT jinkaizhou theroleofnecroptosisincancerbiologyandtherapy AT niquanxing theroleofnecroptosisincancerbiologyandtherapy AT yuxianjun theroleofnecroptosisincancerbiologyandtherapy AT liuchen theroleofnecroptosisincancerbiologyandtherapy AT gongyitao roleofnecroptosisincancerbiologyandtherapy AT fanzhiyao roleofnecroptosisincancerbiologyandtherapy AT luoguopei roleofnecroptosisincancerbiologyandtherapy AT yangchao roleofnecroptosisincancerbiologyandtherapy AT huangqiuyi roleofnecroptosisincancerbiologyandtherapy AT fankun roleofnecroptosisincancerbiologyandtherapy AT chenghe roleofnecroptosisincancerbiologyandtherapy AT jinkaizhou roleofnecroptosisincancerbiologyandtherapy AT niquanxing roleofnecroptosisincancerbiologyandtherapy AT yuxianjun roleofnecroptosisincancerbiologyandtherapy AT liuchen roleofnecroptosisincancerbiologyandtherapy |